NP0341902 | 8´-en-achillinin | | | C30H34O8
522.5940 Da 522.22537 Da | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
NP0341903 | 7-en-13-hytanaphallin | | | C15H18O5
278.3040 Da 278.11542 Da | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
NP0341904 | argyinolide O | | | C30H34O6
490.5960 Da 490.23554 Da | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
NP0341905 | (+)-8-acetylarteminolide | | | C32H36O8
548.6320 Da 548.24102 Da | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
NP0341907 | 13β-taxusin | | | C28H40O8
504.6200 Da 504.27232 Da | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) |
|
NP0341908 | 1β-hydroxytaxusin | | | C28H40O9
520.6190 Da 520.26723 Da | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
NP0341917 | pullenvalene E | | | C48H82N2O15
927.1830 Da 926.57152 Da | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 151 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) |
|
NP0341918 | pullenvalene F | | | C48H82N2O16
943.1820 Da 942.56643 Da | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 151 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) |
|
NP0341919 | pullenvalene G | | | C38H65NO10
695.9350 Da 695.46085 Da | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 151 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) |
|
NP0341920 | pullenvalene H | | | C47H80N2O15
913.1560 Da 912.55587 Da | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | 1H NMR Spectrum (1D, 600 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 151 MHz, C5D5N, experimental) |
|
NP0341923 | N-vanillyl-4E,6E-dien-8-methylnonanamide | | | C18H25NO3
303.4020 Da 303.18344 Da | 1H NMR Spectrum (1D, 500 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) |
|
NP0341924 | ω-hydroxycapsaicin | | | C18H27NO4
321.4170 Da 321.19401 Da | 1H NMR Spectrum (1D, 500 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) |
|
NP0341925 | N-heptanoate vanillylamide | | | C15H23NO3
265.3530 Da 265.16779 Da | 1H NMR Spectrum (1D, 500 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) |
|
NP0341926 | nornordihydrocapsaicin | | | C16H25NO3
279.3800 Da 279.18344 Da | 1H NMR Spectrum (1D, 500 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) |
|
NP0341927 | N-Isovalerylvanillylamin | | | C13H19NO3
237.2990 Da 237.13649 Da | 1H NMR Spectrum (1D, 500 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) |
|
NP0341928 | N-(4-hydroxy-3-methoxybenzyl)-8-methyl-7-oxononanamide | | | C18H27NO4
321.4170 Da 321.19401 Da | |
NP0341929 | Epicapsaicin | | | C18H27NO4
321.4170 Da 321.19401 Da | |
NP0341930 | N-vanillyl-9-hydroxydecanamide | | | C18H29NO4
323.4330 Da 323.20966 Da | 1H NMR Spectrum (1D, 500 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) |
|
NP0341931 | N-vanillyl-7-hydroxy-8-methylnonamide | | | C18H29NO4
323.4330 Da 323.20966 Da | 1H NMR Spectrum (1D, 500 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) |
|
NP0341932 | N-vanillyl 6-Methyl-2,4-heptadienamide | | | C16H21NO3
275.3480 Da 275.15214 Da | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0341933 | 5,5'-dicapsaicin | | | C36H52N2O6
608.8200 Da 608.38254 Da | 1H NMR Spectrum (1D, 500 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) |
|
NP0341934 | N-vanillylbutyramide | | | C12H17NO3
223.2720 Da 223.12084 Da | 1H NMR Spectrum (1D, 500 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) |
|
NP0341935 | N-vanillyl-isobutyramide | | | C12H17NO3
223.2720 Da 223.12084 Da | 1H NMR Spectrum (1D, 500 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) |
|
NP0341936 | N-vanillyl-capsaicin ether | | | C26H35NO5
441.5680 Da 441.25152 Da | 1H NMR Spectrum (1D, 600 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) |
|
NP0341943 | Eremoxylarin D | | | C23H32O6
404.5030 Da 404.21989 Da | 1H NMR Spectrum (1D, 500, C3D6O, simulated) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|